Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS.

NEJM evidence·2025

Same author

Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.

Frontiers in immunology·2025

Same author

Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes.

Frontiers in transplantation·2024

Same author

CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation.

iScience·2024

Same author

Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes.

NEJM evidence·2024

Same author

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.

Frontiers in immunology·2023

Same journal

Are electrical stimulation devices the way forward for addressing heavy menstrual bleeding in women with von Willebrand disease?

Expert review of hematology·2026

Same journal

Embedding cardiovascular risk assessment into routine BTK inhibitor management in chronic lymphocytic leukemia.

Expert review of hematology·2026

Same journal

The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.

Expert review of hematology·2026

Same journal

Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care.

Expert review of hematology·2026

Same journal

Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison.

Expert review of hematology·2026

Same journal

Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis.

Expert review of hematology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 20, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Bridging the gap in hematological malignancies.

Simrit Parmar¹, Swami Padmanabhan Iyer

¹Anderson Cancer Center, Houston, TX, USA. sparmar@mdanderson.org

Expert Review of Hematology

|July 12, 2012

Summary

This summary is machine-generated.

The 3rd International Hematologic Malignancies Conference in Hong Kong fostered scientific exchange on leukemia, lymphoma, and myeloma. It connected Asia-Pacific experts with global leaders to advance cancer research.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Area of Science:

Hematology Oncology
Cancer Research

Background:

The 3rd International Hematologic Malignancies Conference convened in Hong Kong.
This event followed successful BTG Series meetings in Singapore in 2010 and 2011.
The conference aimed to advance scientific discourse within the Asia-Pacific region.

Framework:

The conference focused on hematologic malignancies, including leukemia, lymphoma, and myeloma.
It featured world-renowned medical faculty and discussion forums.
The event served as a platform for exchanging ideas among the Asia-Pacific hematology oncology healthcare community.

Implementation:

Attendees interacted with field leaders and were exposed to the latest research.
Practicing physicians and fellows in training engaged with global thought leaders.
Key opinion leaders from the Asia-Pacific region, USA, and Europe convened.

Implications:

The conference fostered a global community dedicated to the fight against cancer.
It provided a platform for younger researchers to present their work internationally.
BTG recognized the significant contributions of Asia-Pacific physicians in the field.